PDCD1 and diffuse large B-cell lymphoma: However, the efficacy of anti-PD-1 immunotherapy in non-Hodgkin lymphomas (NHLs) including diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) has been more modest (4).